390 related articles for article (PubMed ID: 16220768)
1. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
2. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
3. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
4. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
5. The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
Jindabanjerd K; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S147-51. PubMed ID: 17726816
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
7. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O
Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358
[TBL] [Abstract][Full Text] [Related]
8. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Murat Naki M; Tekcan C; Ozcan N; Cebi M
Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
[TBL] [Abstract][Full Text] [Related]
10. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine device use among women with uterine fibroids: a systematic review.
Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
[TBL] [Abstract][Full Text] [Related]
12. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
14. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
[TBL] [Abstract][Full Text] [Related]
16. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Bragheto AM; Caserta N; Bahamondes L; Petta CA
Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
19. The levonorgestrel-releasing intrauterine device.
Toivonen J
Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
[TBL] [Abstract][Full Text] [Related]
20. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
Lukes AS; Reardon B; Arepally G
Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
